[L’Oréal], whose portfolio includes Garnier, Maybelline and Lancôme, reported a 5.3% increase in net profit to EUR 3.55 billion for the period from January to June, compared with the same period a year earlier. Revenue rose to nearly EUR 23.8 billion, supported in particular by strong performances in professional products, such as Kérastase, and dermatological brands, including La Roche-Posay and Vichy.
— Read more in L’Oréal: dermatological division drive first-half sales growth at Premium Beauty News.
L’Oréal Luxe recorded adjusted like-for-like growth of +5.1%, advancing at twice the pace of the global selective beauty market. Fragrances remained the standout category, supported by Prada Paradigme, Emporio Armani, Yves Saint Laurent Libre, MYSLF and Valentino Born in Roma. The division also benefitted from accelerating skincare sales and the addition of the Gucci beauty licence to its long-term portfolio.
— Read more in L’Oréal outperforms beauty market in H1 with +6.5% sales uplift; Asia travel retail recovery expected in H2 at Moodie Davitt Report.